A new nasal-delivered nanotherapy shows promise against aggressive glioblastoma tumors. By activating the STING immune pathway using gold-core spherical nucleic acids, researchers were able to reach ...

Glioblastoma is one of the most lethal brain cancers known, and for decades treatment has barely budged survival curves despite surgery, radiation, and chemotherapy. Now researchers are testing a ...

WINSTON-SALEM, N.C., July 23, 2025 — A groundbreaking brain imaging study from Wake Forest University School of Medicine confirms a vital step toward new Alzheimer’s disease treatments: Intranasal ...

A groundbreaking brain imaging study from Wake Forest University School of Medicine confirms a vital step toward new Alzheimer's disease treatments: Intranasal insulin, delivered via a simple nasal ...

Polyrizon Ltd., a biotech company based in Raanana, Israel, has announced the filing of a divisional patent application for its Trap & Target (T&T) platform technology with the Israel Patent Office.

WINSTON-SALEM, N.C., Oct. 16, 2025 — A clinical trial from Wake Forest University School of Medicine shows that two widely available medications, the diabetes drug empagliflozin (Jardiance) and ...

NodThera has developed first-in-class small-molecule inhibitors of the NLRP3 inflammasome, a master switch for inflammation, and is charting a clinical path to patients in multiple indications. Many ...